Jushi Holdings (JUSHF) Current Assets (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Current Assets came in at $84.7 million in Q1 2026, up 23.34% year-on-year from $68.7 million in Q1 2025, and up 23.95% on a QoQ basis from $68.3 million in Q4 2025.
Jushi Holdings (JUSHF) Current Assets (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Current Assets data on file, last reported at $84.7 million in Q1 2026.
- On a quarterly basis, Current Assets rose 23.34% year-over-year to $84.7 million in Q1 2026; TTM through Mar 2026 was $84.7 million, a 23.34% increase from a year earlier, with the FY2025 full-year figure at $68.3 million, down 5.32% from the prior year.
- Current Assets for Q1 2026 stood at $84.7 million, up from $68.3 million in the prior quarter.
- Over the last five years, Current Assets for JUSHF reached as high as $122.6 million in Q1 2022 and fell as low as $64.2 million in Q2 2025.
- Historically, Current Assets has averaged $80.9 million across 5 years, with a median of $81.5 million in 2024.
- Across the five-year window, Current Assets sank 54.62% in 2022 and rose 27.51% in 2024, its largest moves.
- Year by year, Current Assets stood at $70.1 million in 2022, then gained by 16.54% to $81.6 million in 2023, then slipped by 11.62% to $72.1 million in 2024, then declined by 5.32% to $68.3 million in 2025, then rose by 23.95% to $84.7 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $84.7 million in Q1 2026, $68.3 million in Q4 2025, and $68.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 84.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.68 Mn |
| Dec 31, 2025 | 68.31 Mn |
| Sep 30, 2025 | 68.60 Mn |
| Jun 30, 2025 | 64.23 Mn |
| Mar 31, 2025 | 68.65 Mn |
| Dec 31, 2024 | 72.15 Mn |
| Sep 30, 2024 | 81.54 Mn |
| Jun 30, 2024 | 88.78 Mn |
| Mar 31, 2024 | 83.00 Mn |
| Dec 31, 2023 | 81.64 Mn |
| Sep 30, 2023 | 88.26 Mn |
| Jun 30, 2023 | 90.29 Mn |
| Mar 31, 2023 | 65.09 Mn |
| Dec 31, 2022 | 70.05 Mn |
| Sep 30, 2022 | 80.87 Mn |
| Jun 30, 2022 | 97.27 Mn |
| Mar 31, 2022 | 122.63 Mn |
| Dec 31, 2021 | 154.36 Mn |